These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 19762359

  • 1. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Guillevin L, Holland M, Kirwan JR, Rovensky J, Saag KG, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
    [Abstract] [Full Text] [Related]

  • 2. Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.
    van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, Caeyers N, Cutolo M, Da Silva JA, Guillevin L, Kirwan JR, Rovensky J, Severijns G, Webber S, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2010 Nov; 69(11):1913-9. PubMed ID: 20693273
    [Abstract] [Full Text] [Related]

  • 3. EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    Hoes JN, Jacobs JW, Boers M, Boumpas D, Buttgereit F, Caeyers N, Choy EH, Cutolo M, Da Silva JA, Esselens G, Guillevin L, Hafstrom I, Kirwan JR, Rovensky J, Russell A, Saag KG, Svensson B, Westhovens R, Zeidler H, Bijlsma JW.
    Ann Rheum Dis; 2007 Dec; 66(12):1560-7. PubMed ID: 17660219
    [Abstract] [Full Text] [Related]

  • 4. Management of patients with rheumatoid arthritis in Latin America: a consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide.
    Massardo L, Suárez-Almazor ME, Cardiel MH, Nava A, Levy RA, Laurindo I, Soriano ER, Acevedo-Vázquez E, Millán A, Pineda-Villaseñor C, Galarza-Maldonado C, Caballero-Uribe CV, Espinosa-Morales R, Pons-Estel BA.
    J Clin Rheumatol; 2009 Jun; 15(4):203-10. PubMed ID: 19502907
    [Abstract] [Full Text] [Related]

  • 5. Toward safer treatment with glucocorticoids: via patient and rheumatologist perspectives to recommendations on monitoring for adverse events.
    van der Goes MC, Jacobs JW, Bijlsma JW.
    Clin Exp Rheumatol; 2011 Jun; 29(5 Suppl 68):S116-20. PubMed ID: 22018196
    [Abstract] [Full Text] [Related]

  • 6. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.
    Duru N, van der Goes MC, Jacobs JW, Andrews T, Boers M, Buttgereit F, Caeyers N, Cutolo M, Halliday S, Da Silva JA, Kirwan JR, Ray D, Rovensky J, Severijns G, Westhovens R, Bijlsma JW.
    Ann Rheum Dis; 2013 Dec; 72(12):1905-13. PubMed ID: 23873876
    [Abstract] [Full Text] [Related]

  • 7. ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version.
    Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J, PARE/EULAR patient initiative group.
    Ann Rheum Dis; 2009 Sep; 68(9):1381-6. PubMed ID: 18930993
    [Abstract] [Full Text] [Related]

  • 8. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J.
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [Abstract] [Full Text] [Related]

  • 9. Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort.
    Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F.
    Rheumatology (Oxford); 2010 Jan; 49(1):147-55. PubMed ID: 19933784
    [Abstract] [Full Text] [Related]

  • 10. EULAR recommendations for the management of large vessel vasculitis.
    Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group.
    Ann Rheum Dis; 2009 Mar; 68(3):318-23. PubMed ID: 18413441
    [Abstract] [Full Text] [Related]

  • 11. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
    Sidiropoulos PI, Hatemi G, Song IH, Avouac J, Collantes E, Hamuryudan V, Herold M, Kvien TK, Mielants H, Mendoza JM, Olivieri I, Østergaard M, Schachna L, Sieper J, Boumpas DT, Dougados M.
    Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
    [Abstract] [Full Text] [Related]

  • 12. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
    Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP, Hauselmann HJ, Herrero-Beaumont G, Jordan K, Kaklamanis P, Leeb B, Lequesne M, Lohmander S, Mazieres B, Martin-Mola E, Pavelka K, Pendleton A, Punzi L, Swoboda B, Varatojo R, Verbruggen G, Zimmermann-Gorska I, Dougados M, EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
    Ann Rheum Dis; 2005 May; 64(5):669-81. PubMed ID: 15471891
    [Abstract] [Full Text] [Related]

  • 13. Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis.
    van Tuyl LH, Plass AM, Lems WF, Voskuyl AE, Kerstens PJ, Dijkmans BA, Boers M.
    Rheumatology (Oxford); 2008 Oct; 47(10):1571-6. PubMed ID: 18710900
    [Abstract] [Full Text] [Related]

  • 14. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT.
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [Abstract] [Full Text] [Related]

  • 15. EULAR recommendations for the management of primary small and medium vessel vasculitis.
    Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R, European Vasculitis Study Group.
    Ann Rheum Dis; 2009 Mar; 68(3):310-7. PubMed ID: 18413444
    [Abstract] [Full Text] [Related]

  • 16. Dissemination and evaluation of the European League Against Rheumatism recommendations for the role of the nurse in the management of chronic inflammatory arthritis: results of a multinational survey among nurses, rheumatologists and patients.
    van Eijk-Hustings Y, Ndosi M, Buss B, Fayet F, Moretti A, Ryan S, Savel C, Scholte-Voshaar M, de la Torre-Aboki J, van Tubergen A.
    Rheumatology (Oxford); 2014 Aug; 53(8):1491-6. PubMed ID: 24692574
    [Abstract] [Full Text] [Related]

  • 17. Outpatient follow-up for patients with rheumatoid arthritis in relation to New Zealand Rheumatology Association guidelines at Dunedin Hospital.
    Chan G, Goh F, Hodgson T, Hsu E, Johnstone D, Ly J, Platt T, Rodrigues E, Tsai W, Hider P, Gray A, Highton J.
    N Z Med J; 2008 May 23; 121(1274):34-41. PubMed ID: 18535644
    [Abstract] [Full Text] [Related]

  • 18. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases.
    Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Koné-Paut I, Fasth A, Minden K, Ravelli A, Abinun M, Pileggi GS, Borte M, Wulffraat NM, EULAR.
    Ann Rheum Dis; 2011 Oct 23; 70(10):1704-12. PubMed ID: 21813547
    [Abstract] [Full Text] [Related]

  • 19. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
    van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR.
    Clin Ther; 2009 Aug 23; 31(8):1737-46. PubMed ID: 19808132
    [Abstract] [Full Text] [Related]

  • 20. [Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients].
    Gómez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Cañete JD, Collantes Estévez E, Fernández Carballido C, Fernández Sueiro JL, García de Vicuña R, González-Álvaro I, González Fernández C, Juanola X, Linares LF, Marenco JL, Martín Mola E, Moreno Ramos M, Mulero Mendoza J, Muñoz Fernández S, Queiro R, Richi Alberti P, Sanz J, Tornero Molina J, Zarco Montejo P, Carmona L, Sociedad Española de Reumatología.
    Reumatol Clin; 2011 Aug 23; 7(5):284-98. PubMed ID: 21925444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.